PERP May Affect the Prognosis of Lung Adenocarcinoma by Inhibiting Apoptosis
Open Access
- 1 March 2024
- journal article
- research article
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 16, 199-214
Abstract
Background: PERP, a member of the peripheral myelin protein gene family, is a new therapeutic target in cancer. The relationships between PERP and immune cell infiltration in lung cancer have not been studied. Therefore, the role of PERP in the tumour microenvironment (TME) of lung cancer needs to be further explored. Methods: In this study, we explored the association between PERP expression and clinical characteristics by analysing data from the TCGA database. Cox regression and Kaplan‒Meier methods were used to investigate the relationship between the expression of PERP and overall survival in patients with lung adenocarcinoma (LUAD). The relationship between PERP expression and the degree of infiltration of specific immune cell subsets in LUAD was evaluated using the TIMER database and GEPIA. We also performed GO enrichment analysis and KEGG enrichment analysis to reveal genes coexpressed with PERP using the Coexpedia database. Finally, we verified the expression and function of PERP in LUAD tissues and the A549 cell line by RT‒PCR, Western blot, CCK-8, IHC, and wound healing assays. The mouse model was used to study the in vivo effects of PERP. Results: According to our results, PERP expression was significantly higher in LUAD tissues and associated with the clinical characteristics of the disease. Survival was independently associated with PERP in LUAD patients. We further verified that PERP might regulate B-cell infiltration in LUAD to affect the prognosis of LUAD. To identify PERP-related signalling pathways in LUAD, we performed a genome-aggregation analysis (GSEA) between low and high PERP expression datasets. LUAD cells express higher levels of PERP than paracarcinoma cells, and PERP inhibits the proliferation and metastasis of A549 cells through apoptosis. Conclusion: PERP may affect the prognosis of lung adenocarcinoma by inhibiting apoptosis and is associated with immune cell infiltration.Keywords
All Related Versions
This publication has 53 references indexed in Scilit:
- An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinomaCancer Immunology, Immunotherapy, 2020
- Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinomaFrontiers of Medicine, 2020
- Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitanceCellular and Molecular Life Sciences, 2020
- Pilot study of loss of the p53/p63 target gene PERP at the surgical margin as a potential predictor of local relapse in head and neck squamous cell carcinomaHead & Neck, 2020
- Biomarkers for immune checkpoint inhibition in non–small cell lung cancer (NSCLC)Cancer, 2019
- Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancerEndocrine, 2019
- The Role of Tumor Microenvironment in Cancer Immunotherapy2017
- EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2017
- Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapySurgery Today, 2017
- ZNF385B is characteristically expressed in germinal center B cells and involved in B‐cell apoptosisEuropean Journal of Immunology, 2012